Dr Reddys Laboratories (RDY) Amortization (2012 - 2026)

Dr Reddys Laboratories' Amortization history runs 14 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Amortization rose 2.81% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 2.81% YoY), while the FY2026 annual figure was $1.2 billion, up 3.93% from the prior year.
• Amortization was $1.1 billion for Q1 2026 at Dr Reddys Laboratories, down from $1.2 billion in the prior quarter.
• In the past five years, Amortization ranged from a high of $1.2 billion in Q3 2025 to a low of $286.7 million in Q3 2023.
• Historically, Amortization has averaged $710.2 million across 5 years, with a median of $444.9 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Amortization declined 28.01% in 2023, then soared 283.56% in 2024.
• A 5-year view of Amortization shows it stood at $398.3 million in 2022, then slipped by 28.01% to $286.7 million in 2023, then jumped by 283.56% to $1.1 billion in 2024, then advanced by 5.22% to $1.2 billion in 2025, then declined by 0.69% to $1.1 billion in 2026.
• The last three Amortization figures came in at $1.1 billion (Q1 2026), $1.2 billion (Q3 2025), and $1.1 billion (Q1 2025), per Business Quant data.